Corvus Pharmaceuticals, Inc.·4

May 7, 5:06 PM ET

Jones William Benton 4

4 · Corvus Pharmaceuticals, Inc. · Filed May 7, 2024

Insider Transaction Report

Form 4
Period: 2024-05-06
Transactions
  • Purchase

    Common Stock

    2024-05-06$1.73/sh+20,000$34,624153,773 total
  • Purchase

    Warrant (Right to Buy)

    2024-05-06+19,35719,357 total
    Exercise: $3.50From: 2024-05-06Exp: 2025-06-30Common Stock (19,357 underlying)
Footnotes (1)
  • [F1]Issued at no additional consideration to the Reporting Person in connection with their subscription for shares of the Issuer's Common Stock at a price of $1.7312.

Documents

1 file
  • 4
    form4.xmlPrimary